Moderna Inc (NASDAQ:MRNA)

118.35
Delayed Data
As of Sep 30
 +0.22 / +0.19%
Today’s Change
115.03
Today|||52-Week Range
376.65
-53.40%
Year-to-Date
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
6:00am / MotleyFool.com - Paid Partner Content
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know
Sep 28 / Zacks.com - Paid Partner Content
Why Moderna Was a Sickly Stock Today
Sep 29 / MotleyFool.com - Paid Partner Content
Why Moderna Stock Lagged the Market Today
Sep 28 / MotleyFool.com - Paid Partner Content
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster
Sep 29 / Zacks.com - Paid Partner Content
Why Moderna Stock Crushed the Market Today
Sep 27 / MotleyFool.com - Paid Partner Content
Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids
Sep 29 / Zacks.com - Paid Partner Content
Covid-Related Sales Boost BioNTech, Moderna and Gilead
Sep 27 / GuruFocus News - Paid Partner Content
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
Sep 29 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids
Sep 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close118.13
Today’s open118.62
Day’s range118.12 - 122.54
Volume156,405
Average volume (3 months)5,073,625
Market cap$48.4B
Data as of 4:02pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-6.19%
Earnings growth (next 5 years)-36.74%
Revenue growth (last year)+2,191.90%
P/E ratio3.6
Price/Sales5.95
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+2.74+1.04%
ILMNIllumina Inc-3.04-1.57%
----
BMRNBiomarin Pharmaceuti...-0.31-0.36%
Data as of 4:02pm ET, 09/30/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)$4.81
Annual revenue (last year)$18.4B
Annual profit (last year)$12.2B
Net profit margin66.27%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts